Charles A. Reinhart III - 04 Jun 2021 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Financial Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
04 Jun 2021
Transactions value $
-$161,626
Form type
4
Date filed
08 Jun 2021, 16:17
Next filing
11 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale -$162K -2.65K -9.65% $61.04 24.8K 04 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.